Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyotsna Kapoor

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Infectious Disease|April 29, 2021
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it outJyotsna Kapoor, Sumeet Prakash Mirgh, Vishvdeep Khushoo, et al.
Annals of Hematology|April 3, 2021
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patientsDinesh Bhurani, Jyotsna Kapoor, Neha Yadav, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 30, 2018
Haplo-identical Hematopoietic Stem Cell Transplant is a Possible Cure in a Patient with Relapsed Hemophagocytic Lymphohistiocytosis SyndromeJyotsna Kapoor, Rayaz Ahmed, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 ProtocolJyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 5, 2024
HIV Associated Lymphomas: A Double-Edged SwordReema Singh, Jyotsna Kapoor, Nisha Panwar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy EraArchana Sharma, Rayaz Ahmed, Narendra Agrawal, et al.
European Journal of Haematology|July 5, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high riskPallavi Mehta, Jyotsna Kapoor, Aakanksha Singh, et al.
Bone Marrow Transplantation|April 16, 2020
Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALLJyotsna Kapoor, Suman Kumar Pramanik, Pragya Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From IndiaNeha Yadav, Mukul Aggarwal, Pallavi Mehta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or DeeperSumeet Mirgh, Jyotsna Kapoor, Niharika Bhatia, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Infectious Disease|April 29, 2021
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it outJyotsna Kapoor, Sumeet Prakash Mirgh, Vishvdeep Khushoo, et al.
Annals of Hematology|April 3, 2021
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patientsDinesh Bhurani, Jyotsna Kapoor, Neha Yadav, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 30, 2018
Haplo-identical Hematopoietic Stem Cell Transplant is a Possible Cure in a Patient with Relapsed Hemophagocytic Lymphohistiocytosis SyndromeJyotsna Kapoor, Rayaz Ahmed, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 ProtocolJyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 5, 2024
HIV Associated Lymphomas: A Double-Edged SwordReema Singh, Jyotsna Kapoor, Nisha Panwar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy EraArchana Sharma, Rayaz Ahmed, Narendra Agrawal, et al.
European Journal of Haematology|July 5, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high riskPallavi Mehta, Jyotsna Kapoor, Aakanksha Singh, et al.
Bone Marrow Transplantation|April 16, 2020
Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALLJyotsna Kapoor, Suman Kumar Pramanik, Pragya Agrawal, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|November 20, 2019
Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From IndiaNeha Yadav, Mukul Aggarwal, Pallavi Mehta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or DeeperSumeet Mirgh, Jyotsna Kapoor, Niharika Bhatia, et al.
Pageof 3